Moran, Sean P.
Dickerson, Jonathan W.
Cho, Hyekyung P.
Xiang, Zixiu http://orcid.org/0000-0002-1678-209X
Maksymetz, James
Remke, Daniel H.
Lv, Xiaohui
Doyle, Catherine A.
Rajan, Deepa H.
Niswender, Colleen M.
Engers, Darren W.
Lindsley, Craig W.
Rook, Jerri M.
Conn, P. Jeffrey
Article History
Received: 26 September 2017
Revised: 11 February 2018
Accepted: 16 February 2018
First Online: 14 March 2018
Competing interests
: JMR is an inventor on patents that protect different classes of muscarinic receptor allosteric modulators. CWL has consulted for AbbVie and received compensation. He is an inventor on patents that protect different classes of metabotropic glutamate and muscarinic receptor allosteric modulators. Over the past three years, PJC has served on the Scientific Advisory Boards for Michael J. Fox Foundation, Stanley Center for Psychiatric Research Broad Institute (MIT/Harvard), Karuna Pharmaceuticals, Lieber Institute for Brain Development, Clinical Mechanism (POCM) and Proof of Concept (POC) Consortium, and Neurobiology Foundation for Schizophrenia and Bipolar Disorder. He is an inventor on patents that protect different classes of metabotropic glutamate and muscarinic receptor allosteric modulators. CMN is an inventor on patents that protect different classes of metabotropic glutamate and muscarinic receptor allosteric modulators. DWE is an inventor on patents that protect different classes of metabotropic glutamate and muscarinic allosteric modulators. The remaining authors declare no competing interests.